The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Bruker Corp (NASDAQ: BRKR) closed the day trading at $60.07 up 5.61% from the previous closing price of $56.88. In other words, the price has increased by $5.61 from its previous closing price. On the day, 1.3 million shares were traded. BRKR stock price reached its highest trading level at $60.28 during the session, while it also had its lowest trading level at $57.02.
Ratios:
For a better understanding of BRKR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 61.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.11. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 1.66. In the meantime, Its Debt-to-Equity ratio is 1.34 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on December 19, 2024, initiated with a Buy rating and assigned the stock a target price of $72.
On December 10, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $66.
Goldman Upgraded its Sell to Neutral on December 05, 2024, while the target price for the stock was maintained at $60.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 ’24 when PACKER RICHARD A sold 3,350 shares for $57.82 per share. The transaction valued at 193,683 led to the insider holds 80,904 shares of the business.
PACKER RICHARD A bought 3,350 shares of BRKR for $193,683 on Dec 02 ’24. On Nov 18 ’24, another insider, LAUKIEN FRANK H, who serves as the PRESIDENT & CEO of the company, bought 100,000 shares for $50.14 each. As a result, the insider paid 5,014,069 and bolstered with 38,439,563 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 9106491392 and an Enterprise Value of 11430106112. As of this moment, Bruker’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.92, and their Forward P/E ratio for the next fiscal year is 22.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.81 while its Price-to-Book (P/B) ratio in mrq is 5.04. Its current Enterprise Value per Revenue stands at 3.526 whereas that against EBITDA is 20.71.
Stock Price History:
Over the past 52 weeks, BRKR has reached a high of $94.86, while it has fallen to a 52-week low of $48.07. The 50-Day Moving Average of the stock is 3.90%, while the 200-Day Moving Average is calculated to be -8.33%.
Shares Statistics:
Over the past 3-months, BRKR traded about 1.46M shares per day on average, while over the past 10 days, BRKR traded about 1591410 shares per day. A total of 151.59M shares are outstanding, with a floating share count of 102.99M. Insiders hold about 32.06% of the company’s shares, while institutions hold 79.87% stake in the company. Shares short for BRKR as of 1735603200 were 6203642 with a Short Ratio of 4.25, compared to 1732838400 on 3298517. Therefore, it implies a Short% of Shares Outstanding of 6203642 and a Short% of Float of 5.59.
Dividends & Splits
BRKR’s forward annual dividend rate is 0.20, up from 0.2 a year ago. Against a Trailing Annual Dividend Yield of 0.0035161744The stock’s 5-year Average Dividend Yield is 0.29.
Earnings Estimates
A detailed examination of Bruker Corp (BRKR) is currently in progress, with 13.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.53, with high estimates of $0.6 and low estimates of $0.41.
Analysts are recommending an EPS of between $2.44 and $2.36 for the fiscal current year, implying an average EPS of $2.39. EPS for the following year is $2.75, with 14.0 analysts recommending between $3.04 and $2.5.
Revenue Estimates
12 analysts predict $962.89M in revenue for the current quarter. It ranges from a high estimate of $973.38M to a low estimate of $952.48M. As of the current estimate, Bruker Corp’s year-ago sales were $854.5MFor the next quarter, 12 analysts are estimating revenue of $815.71M. There is a high estimate of $830M for the next quarter, whereas the lowest estimate is $799.09M.
A total of 13 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.36B, while the lowest revenue estimate was $3.34B, resulting in an average revenue estimate of $3.35B. In the same quarter a year ago, actual revenue was $2.96BBased on 13 analysts’ estimates, the company’s revenue will be $3.6B in the next fiscal year. The high estimate is $3.62B and the low estimate is $3.56B.
